Heather L Lander1, Julius I Ejiofor2, Siobhan McGurk2, Kaneko Tsuyoshi2, Prem Shekar2, Simon C Body3. 1. Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts. 2. Division of Cardiac Surgery, Department of Surgery, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts. 3. Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts. Electronic address: sbody@partners.org.
Abstract
BACKGROUND: Deep sternal wound infection (DSWI) is a devastating complication that increases morbidity and death in cardiac surgical patients. Vancomycin is often administered intravenously for antibiotic prophylaxis in cardiac operations. Many cardiac surgeons also apply vancomycin paste topically to the sternal edges. We examined the effect of vancomycin paste on the incidence of DSWI in patients undergoing elective cardiac operations. METHODS: We retrospectively reviewed the medical records of all patients from 2003 to 2015 who underwent coronary artery bypass grafting, valve, or combined coronary artery bypass grafting and valve operations at a single institution. We derived The Society for Thoracic Surgeons (STS) DSWI risk index for each patient and systematically reviewed operative, pharmacy, microbiology, and discharge records to document DSWI in these patients. Multivariate analyses were used to identify predictors of DSWI in this cohort and to quantify the effect of vancomycin paste. RESULTS: Of the 14,492 patients whose records we examined, DSWI developed in 136 patients, resulting in an overall incidence of 0.9%. After multivariate analysis, body mass index, New York Heart Association Functional Classification, and the STS DSWI risk index remained statistically significant and associated with DSWI. Although the incidence of DSWI decreased over time, the use of vancomycin paste was not associated with a reduced incidence of DSWI. CONCLUSIONS: There was a marked decrease in the incidence of DSWI during the study period, concurrent with institutional implementation of revised STS antibiotic dosing guidelines in 2007 and other strategies. However, the application of vancomycin paste to the sternal edges of patients undergoing cardiac operations was not associated with a reduced risk of DSWI.
BACKGROUND: Deep sternal wound infection (DSWI) is a devastating complication that increases morbidity and death in cardiac surgical patients. Vancomycin is often administered intravenously for antibiotic prophylaxis in cardiac operations. Many cardiac surgeons also apply vancomycin paste topically to the sternal edges. We examined the effect of vancomycin paste on the incidence of DSWI in patients undergoing elective cardiac operations. METHODS: We retrospectively reviewed the medical records of all patients from 2003 to 2015 who underwent coronary artery bypass grafting, valve, or combined coronary artery bypass grafting and valve operations at a single institution. We derived The Society for Thoracic Surgeons (STS) DSWI risk index for each patient and systematically reviewed operative, pharmacy, microbiology, and discharge records to document DSWI in these patients. Multivariate analyses were used to identify predictors of DSWI in this cohort and to quantify the effect of vancomycin paste. RESULTS: Of the 14,492 patients whose records we examined, DSWI developed in 136 patients, resulting in an overall incidence of 0.9%. After multivariate analysis, body mass index, New York Heart Association Functional Classification, and the STS DSWI risk index remained statistically significant and associated with DSWI. Although the incidence of DSWI decreased over time, the use of vancomycin paste was not associated with a reduced incidence of DSWI. CONCLUSIONS: There was a marked decrease in the incidence of DSWI during the study period, concurrent with institutional implementation of revised STS antibiotic dosing guidelines in 2007 and other strategies. However, the application of vancomycin paste to the sternal edges of patients undergoing cardiac operations was not associated with a reduced risk of DSWI.
Authors: David M Shahian; Sean M O'Brien; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson Journal: Ann Thorac Surg Date: 2009-07 Impact factor: 4.330
Authors: Yi Mu; Jonathan R Edwards; Teresa C Horan; Sandra I Berrios-Torres; Scott K Fridkin Journal: Infect Control Hosp Epidemiol Date: 2011-09-01 Impact factor: 3.254
Authors: Baron L Hamman; Laura Y Stout; Theodore T Theologes; Danielle M Sass; Briget da Graca; Giovanni Filardo Journal: Am J Cardiol Date: 2014-01-31 Impact factor: 2.778
Authors: Teresa M Kieser; M Sarah Rose; Uthman Aluthman; Marlene Montgomery; Thomas Louie; Israel Belenkie Journal: J Thorac Cardiovasc Surg Date: 2014-02-11 Impact factor: 5.209
Authors: Kasra Shaikhrezai; Faye L Robertson; Susan E Anderson; Robert D Slight; Edward T Brackenbury Journal: Interact Cardiovasc Thorac Surg Date: 2012-05-18
Authors: T J Vander Salm; O N Okike; M K Pasque; A T Pezzella; R Lew; V Traina; R Mathieu Journal: J Thorac Cardiovasc Surg Date: 1989-10 Impact factor: 5.209
Authors: Michał Pasierski; Kamil Zieliński; Giuseppe Maria Raffa; Harold Lazar; Roberto Lorusso; Piotr Suwalski; Mariusz Kowalewski Journal: J Thorac Dis Date: 2019-09 Impact factor: 2.895
Authors: Mohammad Abd Alkhalik Basha; Dina Said Shemais; Essam Saad Abdelwahed; Rabab Mahmoud Elfwakhry; Ayman Fathy Zeid; Ahmed A El-Hamid M Abdalla; Sameh Abdelaziz Aly; Dalia Said Abdelrahman; Anwar A Elshenawy; Waleed Mansour; Khaled Ahmed Ahmed Elbanna; Mohammad El Tahlawi; Nezar Elnahal Journal: Int J Gen Med Date: 2021-12-02